Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Almost 600K shares traded US side
View:
Post by N0taP00p on Jan 23, 2023 3:20pm

Almost 600K shares traded US side

Either someone knows something about an impending cash raise or FDA delay, or it is related to warrants like some people are assuming. It is sheer nonsense to assume that someone posting on a stock board is moving the stock. I'm sure we'll know soon enough.
Comment by Rumpl3StiltSkin on Jan 23, 2023 3:32pm
I think someone is taking advantage of running stops. Should be an interesting close and week. :-)
Comment by Scorpio2 on Jan 23, 2023 3:35pm
Yes, I would agree. This is what is called a "flashcrash".
Comment by N0taP00p on Jan 23, 2023 3:36pm
Rumpl3 - If so, we should see a reversal before close?  Someone is buying a lot of shares is another way to look at it. It is a mystery. 
Comment by Impalaman on Jan 23, 2023 3:36pm
Just a heads up---there was a gap down at---0.28 usd----on tltf--they took it down to 0.24.
Comment by TriumphSpitSix on Jan 23, 2023 4:39pm
I grabbed 20k today of those $0.24 cheapies. Been sitting on TLTFF shares so long, I actually averaged UP.
Comment by plantrader on Jan 23, 2023 5:04pm
Volume was fairly lame on the move up last week (not bullish). So I'm not surprised by this and don't really think it matters much right now anyway. This is almost just a binary catalyst (FDA) play in general.
Comment by Nailbiter2 on Jan 23, 2023 5:22pm
V:TLT - Theralase Technologies Inc. - https://www.theralase.com 17:05:31 EST Sym-X Bid - Ask Last Chg %Ch Vol $Vol #Tr Open-Hi-Lo Year Hi-Lo Last Tr News Delay TLT - V  ATS 3.5 0.315 · 0.34  ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250